New York, NY (PRWEB) April 13, 2015
Up until now, patients in Manhattan needed to visit hospitals for their HBOT treatments to heal diabetic foot wounds, delayed radiation injury, bone infections (osteomyelitis), failed skin grafts, and other chronic ailments, but Hyperbaric Medical Solutions has now opened a free-standing, non-hospital based HBOT site at 160 East 32nd Street – its third location in the tri-state area and the first free-standing HBOT site in Manhattan dedicated to hard chamber hyperbaric treatments.
As a free-standing, non-hospital based site, Hyperbaric Medical Solutions offers this innovative, non-invasive, state-of-the-art medical treatment at a fraction of the cost of its hospital counterparts, which is particularly important in an era of high deductibles and co-insurance, hospital copays, and cost sharing policies.
HBOT is simple: patients breathe pure oxygen at increased atmospheric pressure to dramatically enhance and expedite wound healing. Every cell in the body needs oxygen to preserve, repair, and enhance cellular function. HBOT powers these cells by increasing the oxygen carrying capacity of blood by at least 700% .
Dr. Henry Prince, Medical Director of Hyperbaric Medical Solutions, states, “HBOT is a non-pharmacological clinical modality that has applications anytime the body is experiencing hypoxia or inflammation. Many other developed countries have 30-40 approved uses for HBOT while the FDA in the U.S. has so far only approved 14 conditions. We are entering a new growth phase in the industry and we expect approved conditions to increase in coming years as the research matures and patients continue to demand more natural and holistic options for their care.”
A unique aspect of Hyperbaric Medical Solutions is its ability to treat a broader range of conditions. This new Manhattan location provides clinical options to patients that simply didn’t exist before. Unlike hospitals that are self-restricted, as a free-standing hyperbaric site, Hyperbaric Medical Solutions is able to treat both so called ‘on-label’ conditions approved by the FDA (such as diabetic foot wounds and other arterial insufficiencies, delayed radiation injury, bone infections (osteomyelitis), failed skin grafts and flaps, crush injuries, and carbon monoxide poisoning), as well as ‘off-label’ conditions such as Traumatic Brain Injury (TBI), Post Traumatic Stress Disorder (PTSD), concussion, stroke, Lyme Disease, Multiple Sclerosis, and others. For a more comprehensive list of conditions where HBOT may be helpful, go to hyperbaricmedicalsolutions.com/conditions. This website also provides relevant information regarding clinical trial data that support treating both FDA-approved and off label conditions with HBOT.
Hyperbaric Medical Solutions accepts most commercial and Workers Compensation insurance plans as well as Medicare and Tricare. Please see http://www.hyperbaricmedicalsolutions.com/insurance for a full up to date list.
For further information, please visit http://www.HyperbaricMedicalSolutions.com or call 646-742-8888.
More Pharmacology Press Releases